What Headwinds? NVDA Prints Another Stellar Quarter Despite Tariffs & Write offs
Bill Baruch joins the desk to talk through NVDA Earnings and why he’s still a buyer.
Adding this Sleeping Giant-This Healthcare stock could be ready to run, Bill Baruch explains.
Adding this Sleeping Giant — Bill Baruch explains why Edwards Life Sciences just made it into the portfolio. Tune in for the full breakdown. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Trimming Tech Around the Edges
Bill Baruch calls into CNBC’s Halftime Report to break down which tech stocks he’s trimming around the edges—tune in! Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Spotify Falls after Earnings, Here’s Our Take
Spotify falls after earnings. Bill Baruch joins CNBC’s Halftime to break down why he’s still in. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Buying Relative Outperformance
Early this week Bill Baruch of Blue Line Capital bought these three names, find out why. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.
Blue Line Market Outlook (2025-Q2)
Buying the Dip: Nvidia, Broadcom & Meta—Bill Baruch Explains His Moves
Discover Blue Line Capital Submit your information and someone from our team will be in touch.
Tariffs & Tech: Navigating Market Volatility
Bill Baruch joined the desk today to discuss tariffs, tech, and how Blue Line Capital is navigating market volatility. Tune in to learn more! Discover Blue Line Capital Submit your information and someone from our team will be in touch.
February 2025 Market Commentary
Markets produced mixed results in February. U.S. large-cap stocks, as represented by the S&P 500, ended the month down 1.3%, while the U.S. small-cap Russell 2000 Index ended February down 5.3%. U.S. intermediate-term bonds fared well, as the Bloomberg U.S. Aggregate Bond Index gained 2.2%.
The Market’s Inflection Point
Bill Baruch joined the CNBC Halftime Report from Miami to discuss the market dynamic ahead of the Fed, NVDA’s GTC conference, and more. Discover Blue Line Capital Ready to explore how Blue Line Capital can help you achieve your financial goals? Let’s chat! Click the button to get started.